Related Experiment Video
Updated: Jul 10, 2026

09:07
A Human Bone Marrow 3D Model to Investigate the Dynamics and Interactions Between Resident Cells in Physiological or Tumoral Contexts
Published on: December 16, 2022
Human bone marrow mesenchymal stem cells in vivo.
1The Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Rheumatology (Oxford, England)
|November 8, 2007
Summary
Robust methods now identify human bone marrow mesenchymal stem cells (MSCs) as homogeneous cells, phenotypically identical to marrow adventitial reticular cells. Evidence does not support circulating MSCs in healthy individuals.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Stem Cell Research
Background:
- Significant confusion persists regarding the in vivo identity of human bone marrow mesenchymal stem cells (MSCs).
- Established methods for robust identification and purification of BM MSCs are available.
- Human BM MSCs exhibit a homogeneous phenotype, sharing characteristics with marrow adventitial reticular cells (ARCs) and pericytes.
Purpose of the Study:
- To clarify the in vivo identity and characteristics of human bone marrow mesenchymal stem cells (MSCs).
- To address the confusion surrounding MSC markers and their expression patterns.
- To establish a foundation for understanding MSCs in vivo for improved therapeutic development.
Main Methods:
- Extensive panel of markers used for BM MSC characterization.
- Rare cell phenotypical analysis.
- In vitro colony forming unit-fibroblast (CFU-F) assays.
Main Results:
- Diverse MSC markers reported in literature are expressed on the same cell population.
- No compelling evidence suggests BM MSCs circulate in healthy individuals.
- A definitive marker for MSC 'stemness' and multipotentiality remains undefined, as culture-expanded MSCs can retain multipotentiality despite marker loss.
Conclusions:
- Human BM MSCs are a phenotypically homogeneous population, identical to ARCs.
- Current evidence does not support the circulation of MSCs in healthy individuals.
- Understanding MSCs in vivo is crucial for advancing regenerative medicine and tissue engineering therapies.
